Cryoport Inc
$ 9.95
3.22%
14 Apr - close price
- Market Cap 482,664,000 USD
- Current Price $ 9.95
- High / Low $ 10.26 / 9.72
- Stock P/E N/A
- Book Value 9.23
- EPS -0.84
- Next Earning Report 2026-05-06
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.03 %
- ROE -0.08 %
- 52 Week High 11.45
- 52 Week Low 5.21
About
Cryoport, Inc., a life sciences services company, provides temperature controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company is headquartered in Brentwood, Tennessee.
Analyst Target Price
$13.61
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-03 | 2025-11-04 | 2025-08-12 | 2025-05-05 | 2025-03-10 | 2024-11-07 | 2024-08-06 | 2024-05-07 | 2024-03-12 | 2023-11-08 | 2023-08-09 | 2023-05-04 |
| Reported EPS | -0.1712 | -0.18 | -0.28 | -0.3836 | -0.4271 | -0.02 | -0.29 | -0.43 | -1.31 | -0.31 | -0.42 | -0.16 |
| Estimated EPS | -0.2139 | -0.24 | -0.27 | -0.2577 | -0.3064 | -0.29 | -0.39 | -0.35 | -0.29 | -0.3 | -0.24 | -0.19 |
| Surprise | 0.0427 | 0.06 | -0.01 | -0.1259 | -0.1207 | 0.27 | 0.1 | -0.08 | -1.02 | -0.01 | -0.18 | 0.03 |
| Surprise Percentage | 19.9626% | 25% | -3.7037% | -48.8553% | -39.393% | 93.1034% | 25.641% | -22.8571% | -351.7241% | -3.3333% | -75% | 15.7895% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-06 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -0.2 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: CYRX
2026-04-09 01:08:50
This article provides a detailed overview of CRYOPORT INC (NASDAQ:CYRX) stock, including its current price, performance metrics, key statistics, and technical and fundamental analysis ratings from ChartMill. It also covers recent earnings, analyst forecasts, financial highlights, ownership information, and a company profile outlining its logistics solutions for the life science industry.
2026-04-08 22:39:57
Cryoport (CYRX) President and CEO Jerrell Shelton exercised stock options for 50,000 shares at an exercise price of $1.87 per share. Following this transaction, he directly holds 1,126,607 shares of Cryoport common stock and 104,007 remaining options. The options exercised were part of a grant that vested monthly over 48 months starting May 6, 2016, and were set to expire on May 6, 2026.
2026-04-07 23:10:09
Insiders at Cryoport (NASDAQ: CYRX) sold US$1.6 million worth of shares over the last year, with Chairman Jerrell Shelton making the largest individual sale. This occurred despite recent stock gains, and the selling price was even below the current market value, suggesting insiders may have viewed a lower price as reasonable. While insiders still collectively own a notable 3.6% of the company, the consistent selling without any purchases raises concerns about their confidence in the stock's future performance.
2026-04-04 12:09:10
This article analyzes the valuation of Cryoport Inc (CYRX), deeming it to be in the "Fair zone" with a fair price range between $4.45 and $28.16 according to relative valuation methods. It highlights that the current forward PS ratio of 2.09 is considered fair compared to its five-year average. The analysis also notes that CYRX's P/S ratio is significantly above the industry average, suggesting that its premium may be unsustainable despite robust revenue growth.
2026-03-30 23:39:53
Craig-Hallum has initiated coverage on CryoPort (CYRX) with a 'Buy' rating and a new price target of $15.00, reflecting analyst Matthew Hewitt's optimism for the company's future. This new rating adds to a history of positive analyst attention for CryoPort, which specializes in temperature-controlled supply chain solutions for the life sciences industry. Wall Street analysts currently project an average target price of $13.33 for CYRX, with an "Outperform" consensus rating.
2026-03-30 21:39:29
Craig-Hallum has initiated coverage of Cryoport (CYRX) with a buy recommendation. This suggests a positive outlook on the company's stock from the investment banking firm.
